CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.56
-0.08 (-0.75%)
At close: Dec 5, 2025, 4:00 PM EST
10.55
-0.01 (-0.09%)
Pre-market: Dec 8, 2025, 4:00 AM EST
CorMedix Stock Forecast
Stock Price Forecast
The 7 analysts that cover CorMedix stock have a consensus rating of "Strong Buy" and an average price target of $17.43, which forecasts a 65.06% increase in the stock price over the next year. The lowest target is $12 and the highest is $22.
Price Target: $17.43 (+65.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +70.45% | Nov 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +32.58% | Nov 12, 2025 |
| Needham | Needham | Strong Buy Maintains $20 → $16 | Strong Buy | Maintains | $20 → $16 | +51.52% | Nov 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +108.33% | Oct 21, 2025 |
| D. Boral Capital | D. Boral Capital | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +32.58% | Oct 20, 2025 |
Financial Forecast
Revenue This Year
316.43M
from 43.47M
Increased by 627.89%
Revenue Next Year
446.02M
from 316.43M
Increased by 40.95%
EPS This Year
2.50
from -0.30
EPS Next Year
2.52
from 2.50
Increased by 0.73%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 331.3M | 528.2M | ||||
| Avg | 316.4M | 446.0M | ||||
| Low | 297.0M | 292.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 662.1% | 66.9% | ||||
| Avg | 627.9% | 41.0% | ||||
| Low | 583.3% | -7.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.08 | 3.06 | ||||
| Avg | 2.50 | 2.52 | ||||
| Low | 1.87 | 1.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 22.1% | ||||
| Avg | - | 0.7% | ||||
| Low | - | -50.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.